Eli Lilly and Company (LLY) Stock Valuation: P/E Ratio and Intrinsic Value
Is Eli Lilly and Company stock expensive or cheap? This page shows the price-earnings ratio of Eli Lilly and Company for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings (FY 2025).
Earnings basis for the valuation (FY 2025)
| Revenue | 65.18 USD bn |
|---|---|
| Net income | 20.64 USD bn |
| Net margin | 31.7 % |
How the Eli Lilly and Company P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Eli Lilly and Company is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Eli Lilly and Company
What is the LLY P/E ratio?
The P/E ratio divides the Eli Lilly and Company share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of LLY can be compared with its own history.
Is Eli Lilly and Company stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of LLY is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Eli Lilly and Company?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of LLY as the starting point.